|

Docetaxel for Injection (Albumin-bound) Clinical Trials

2 actively recruiting trials

Also known as: HB1801

Pipeline

Phase 2: 1Phase 3: 1

Top Sponsors

  • CSPC ZhongQi Pharmaceutical Technology Co., Ltd.2

Indications

  • Cancer2
  • Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors1
  • Gastric Cancer1

Other2 trials

A Clinical Study of Docetaxel for Injection (Albumin-bound) in Patients With Gastric Cancer
Phase 3
Safety and Efficacy of Glumetinib Combined With Docetaxel for Injection (Albumin-bound) in Patients With Advanced Gastric Cancer/Gastroesophageal Junction Adenocarcinoma and Other Solid Tumors
Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.